List of Studies

Back
Study IDStudy TitleLanguage Clinical Study Result Plain Language Summary
8232-CL-0002A phase 1 study to evaluate the effect of renal impairment on the pharmacokinetics, pharmacodynamics and safety of ASP8232 (part 1) and a multiple dose, placebo-controlled exploratory safety, pharmacokinetic and pharmacodynamic study in type 2 diabetes mellitus subjects with chronic kidney disease (part 2) English


English


8232-CL-0004A Phase 2, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuriain Patients with Type 2 Diabetes and Chronic Kidney Disease English


English


8232-CL-3001A Phase 2, Double-Masked, Randomized, Active Controlled Study to Evaluate the Efficacy and Safety of ASP8232 in Reducing Central Retinal Thickness in Subjects with Diabetic Macular Edema English


English


QUICK SEARCH

USEFUL LINKS